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Abstract
Background: Francisella tularensis is a select bio-threat agent and one of the most virulent intracellular pathogens
known, requiring just a few organisms to establish an infection. Although several virulence factors are known, we
lack an understanding of virulence factors that act through host-pathogen protein interactions to promote
infection. To address these issues in the highly infectious F. tularensis subsp. tularensis Schu S4 strain, we deployed a
combined in silico, in vitro, and in vivo analysis to identify virulence factors and their interactions with host proteins
to characterize bacterial infection mechanisms.
Results: We initially used comparative genomics and literature to identify and select a set of 49 putative and
known virulence factors for analysis. Each protein was then subjected to proteome-scale yeast two-hybrid (Y2H)
screens with human and murine cDNA libraries to identify potential host-pathogen protein-protein interactions.
Based on the bacterial protein interaction profile with both hosts, we selected seven novel putative virulence
factors for mutant construction and animal validation experiments. We were able to create five transposon insertion
mutants and used them in an intranasal BALB/c mouse challenge model to establish 50 % lethal dose estimates.
Three of these, ΔFTT0482c, ΔFTT1538c, and ΔFTT1597, showed attenuation in lethality and can thus be considered
novel F. tularensis virulence factors. The analysis of the accompanying Y2H data identified intracellular protein
trafficking between the early endosome to the late endosome as an important component in virulence attenuation
for these virulence factors. Furthermore, we also used the Y2H data to investigate host protein binding of two
known virulence factors, showing that direct protein binding was a component in the modulation of the
inflammatory response via activation of mitogen-activated protein kinases and in the oxidative stress response.
Conclusions: Direct interactions with specific host proteins and the ability to influence interactions among host
proteins are important components for F. tularensis to avoid host-cell defense mechanisms and successfully
establish an infection. Although direct host-pathogen protein-protein binding is only one aspect of Francisella
virulence, it is a critical component in directly manipulating and interfering with cellular processes in the host cell.
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Background
Francisella tularensis, the causative agent of tularemia
and a Centers for Disease Control and Prevention
Category A select agent, is one of the most infectious
bacteria known, with <10 cells capable of causing severe
infections in humans and animals [1]. Its role as a
biological weapon has been investigated in the United
States (U.S.), the former Soviet Union, and Japan [2], and
it remains both a potential health hazard and a bioterror-
ism threat. F. tularensis is a Gram-negative opportunistic
intracellular pathogen that primarily affects lagomorphs
but can infect virtually any human cell type, although the
primary infection typically goes through macrophages
[3, 4]. As such, F. tularensis is endowed with multiple
robust infection mechanisms, including the ability to
avoid or circumvent host immune defenses [5–11].
Relatively little is known about the detailed molecular
nature of F. tularensis pathogenicity, although recent
progress in high-throughput genomic and proteomic
technologies has contributed to an increase in the
number of experimentally confirmed or predicted genes
involved in its virulence [12]. By definition, inactivation
of these “virulence factors” attenuates or abrogates
virulence in an animal infection model, regardless of
which stages of the infection process they are involved
in. Given the high virulence and large number of identified
virulence factors for this organism, one can surmise that
multiple robust mechanisms are contributing to the
infection process.
Francisella spp. virulence is highly correlated with the
presence of the so-called pathogenicity islands among
the most pathogenic strains and their modification or
absence in non-pathogenic strains. A 33-kbp pathogen-
icity island has been identified in F. tularensis [13], and
systematic mutations confirmed its key role in virulence
[14]. A region of the pathogenicity island encodes a set
of genes that map to a fully functional type VI secretion
system (T6SS) [15, 16]. In F. tularensis, T6SSs play a
central role in manipulating host cells by translocating
virulence factors across the bacterium’s inner and outer
membranes directly into the host cytosol. Alternatively,
bacterial proteins can also be exported to the periplas-
mic space via the universal Sec pathway and then trans-
located across the outer membrane, usually via a type II
secretion system (T2SS) [17, 18]. The identity of the
specific proteins translocated through these systems
and their interactions with host proteins or other
factors in the host cell are not well characterized.
However, host-pathogen interactions provide a means
to identify virulence factors that are directly related
to protein interactions and ascertain their associated
mechanisms of infectivity [19, 20].
Accordingly, we deployed a bioinformatics-based ap-
proach to initially select F. tularensis subsp. tularensis
Schu S4 proteins broadly associated with secretion and
filtered the selected putative virulence factors through
whole-genome human and murine yeast two-hybrid
(Y2H) screens to select unstudied bacterial proteins that
exhibited host-pathogen protein-protein interactions
(PPIs). Seven of these bacterial proteins were selected
for transposon mutant construction, five of which were
successfully obtained and used in an intranasal BALB/c
mouse challenge model to ascertain in vivo virulence.
Three of these, ΔFTT0482c, ΔFTT1538c, and ΔFTT1597,
showed a statistically significant reduction in lethality
compared with the wild-type strain and can, thus, be
considered novel virulence factors. Based on the accom-
panying Y2H data, we could also generate hypoth-
eses about the underlying host mechanisms targeted
by infecting bacteria.
Methods
Bioinformatics and literature-based identification of
potential virulence factor proteins
We initially identified and collected putative Francisella
spp. virulence factor proteins based on comparative
genomics between high- and low-pathogenicity strains,
the presence of VgrG domains as indicative of T6SS
association [21], model predictions of signaling sequences,
and literature-based searches. We obtained all Francisella
genomes from the PathoSystems Resource Integration
Center database [22].
Using QuartetS [23, 24], we performed whole-genome
comparisons of six highly pathogenic F. tularensis strains
with eight less pathogenic F. tularensis strains and seven
F. novicida strains (Additional file 1: Table S1) to iden-
tify proteins present only in the highly pathogenic
strains. To identify putative VgrG proteins, we initially
downloaded VgrG domain-containing genes from the
National Center for Biotechnology Information (NCBI)
database [25]. Using BLAST [26], we compared the F.
tularensis subsp. tularensis Schu S4 genome with all
other VgrG domain-containing genes and identified
putative F. tularensis VgrG genes based on homology.
We considered two genes as homologs if the E-value of
their alignment was ≤0.01.
We used SignalP to predict the presence and location
of signal peptide cleavage sites in amino acid sequences
of the F. tularensis subsp. tularensis Schu S4 genome
[27]. In prokaryotes, these signal peptides constitute
ubiquitous protein-sorting signals that target their
passenger proteins for translocation across the cytoplas-
mic membrane, although the presence of the signal
peptide does not guarantee that a protein is secreted.
We used both the hidden Markov model method and the
neural network method in SignalP to identify F. tularensis
proteins with signal peptides to tag them as putatively
secreted proteins. We used default cutoff values for both
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methods and designated putative signaling proteins as
those proteins identified using both methods.
High-throughput Y2H screens to identify human-F.
tularensis PPIs
We cloned the known and predicted F. tularensis
virulence factor genes from F. tularensis subsp. tularensis
Schu S4 genomic DNA. All F. tularensis virulence factor
genes were PCR amplified using gene-specific primers
incorporated with forward and reverse Gateway recom-
bination cloning sequences, i.e., attB1 (5’-GGGGAC
AAGTTTGTACAAAAAAGCAGGCTTC-3’) and attB2
(5’-GGGGACCACTTTGTACAAGAAAGCTGGGTC-3’),
respectively. The PCR-amplified open reading frames
(ORFs) were cloned into Gateway entry vector pDONR221™
as recommended by the BP Clonase™ II enzyme provider
(Invitrogen, Carlsbad, CA). We validated the entry vectors
with the cloned ORFs by Sanger sequencing.
Entry clones were sub-cloned into Y2H bait (DNA-
binding domain) vectors, pGBGT7g (as NH2-terminal
fusion) and pGBACg (C-terminal fusion) [28], using
Gateway LR reactions (Invitrogen). Y2H bait clones were
subsequently transferred into the haploid yeast strain
AH109 (MAT-α), as previously described [29]. Before
the two-hybrid analyses, we examined all baits in yeast
strains for auto-activation, i.e., detectable bait-dependent
reporter gene activation in the absence of any interacting
protein. We used the HIS3 reporter gene, and auto-
activation was titrated by adding different concentrations
of 3-amino-1,2,4-triazole (3-AT), a competitive inhibitor
of HIS3. All F. tularensis baits were inspected for auto-
activation on plates containing different concentrations
of 3-AT. The lowest concentration of 3-AT that sup-
pressed growth for the interaction screen was used
because it avoided background growth while still
detecting true interactions.
A haploid yeast strain expressing each F. tularensis
protein as bait was used for the PPI screening with
human and mouse normalized universal cDNA libraries
(catalog nos. 630480 and 630482, Clontech Laboratories,
Mountain View, CA). The bait and prey yeast culture
was grown and mixed at a 1:1 ratio and plated on yeast
extract, peptone, dextrose, and adenine (YEPDA) agar
plates. YEPDA agar plates were incubated at 30 °C for
6 h or overnight at room temperature. During this
process, both prey and bait plasmids were combined in
diploid yeast cells by yeast mating. Cells from the mating
plates were collected and transferred onto interaction-
selection yeast-synthetic medium with predefined con-
centrations of 3-AT (media lacking tryptophan, leucine,
and histidine plus 3-AT), and plates were incubated at
30 °C for 4–6 days. The interaction-selection plates that
showed colony growth but no colonies on control plates
(bait mated to empty prey vector) were identified as
two-hybrid positive yeast clones. Positive yeast col-
onies were selected manually and subjected to yeast
colony PCR followed by DNA sequencing to identify
the interacting preys [29].
Pairwise Y2H retesting of human-F. tularensis high-
throughput PPIs
To increase confidence in selected human-F. tularensis
virulence factor protein interactions, we designated 12
interaction pairs identified in the high-throughput Y2H
library screening for retesting in pairwise Y2H assays.
Human prey clones were constructed by sub-cloning the
ORFs from the Human ORFeome collection [30] or
amplifying the ORF from the Mammalian Gene Collection
library [31] and subsequently transferred into the two
Y2H prey vectors (pGADT7g and pGBACg). The pairwise
Y2H assays were performed with activation tests
conducted side by side as previously described [29].
Generation of transposon insertion mutants
The F. tularensis subsp. tularensis Schu S4 strain used in
this study was derived from a U.S. Army Medical
Research Institute for Infectious Diseases (USAMRIID)
stock of an F. tularensis isolate obtained from a U.S.
patient in 2005 and supplied by McKesson BioServices
(Rockville, MD). A seed stock of that strain was passaged
twice through mice, and single colony isolates were
collected, pooled, and labeled FT12. In these experiments,
in vitro culturing of FT12 was done at 37 °C in enhanced
tularemia broth (ETB) consisting of trypticase soy broth
(Becton Dickinson, Franklin Lakes, NJ) supplemented
with cysteine (0.1 %), glucose (0.1 %), ferric pyrophosphate
(0.25 %), and horse serum (2.5 %). Growth of FT12 on
solid medium was done on enhanced tularemia agar
(ETA) plates consisting of Mueller-Hinton II agar (Becton
Dickinson) supplemented with NaCl (2.5 g/l), protease
peptone (5 g/l), cysteine (0.1 %), glucose (0.1 %), ferric
pyrophosphate (0.25 %), and horse serum (2.5 %).
Plasmid pGreenhopper (T.A. Hoover, unpublished
data) was constructed in plasmid pCR2.1-TOPO (Life
Technologies, Frederick, MD) and carries a modified
Mariner-based Himar 1 transposon and flanking trans-
posase gene. Within the inverted DNA repeats that
define the termini of the transposon is a kanamycin
resistance gene positioned downstream of the promoter
for the FT12 groESL operon to allow for selection of
cells harboring transposon insertions. pGreenhopper
was electroporated into FT12, diluted, and plated on 20
ETA plates. Approximately 2,000 colonies per plate were
scraped and pooled for use in high-throughput mutagen-
esis screening experiments. Southern blot analysis of 30
independent F. tularensis transposon recipients suggested
that the library was random and that transposition events
occurred once per cell, presumably due to the lack of
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replication of pGreenhopper in F. tularensis and the
conservative cut-and-paste mode of replication character-
istic of Mariner family transposable elements.
Specific F. tularensis Schu S4 mutants were isolated
from the pooled collection of approximately 40,000
independent transposon insertion mutants by nested
PCR detection with progressively smaller library subsets.
Primers that annealed downstream of a gene of interest
were paired with primers that annealed to the terminal
repeats of the inserted transposon in PCRs containing
small aliquots of whole cells from subsets of the F. tular-
ensis library (Table 1). Subsets giving rise to appropri-
ately sized DNA bands from these reactions were
cultured on ETA plates to obtain smaller subsets, and
the process was repeated until single colony isolates
were obtained and stored at -80 °C. Genomic DNAs
were prepared from these clones and re-analyzed by
PCR to confirm the presence of the transposon within
the coding sequence of each gene. In two cases (FTT1538c
and FTT1564), insertion sites were determined by
DNA sequencing.
Animal experimentation
BALB/c mice have been widely used and accepted for the
experimental study of tularemia and was the animal model
chosen for these experiments. Female BALB/c mice at
6–9 wk of age were obtained and intranasally adminis-
tered doses of wild-type F. tularensis Schu S4 and
selected mutants, and then observed for 21 days. Mori-
bund mice and mice surviving to day 21 post-challenge
were euthanized in accordance with USAMRIID Standard
Operating Procedure AC-11–04–05.
Challenge doses were prepared from overnight F.
tularensis cultures grown at 37 °C on ETA plates. Cells
were scraped and diluted in phosphate-buffered saline
solution to obtain appropriate numbers of cells in each
dose. Intranasal installations of 33 μl/mouse were
followed by 10-μl washes in each nostril. Mice were
Table 1 Primers, plasmids, and strains used in the mouse intranasal challenge model experiments





















pCR2.1-TOPO 3,931-bp TA vector; pMB1 oriR; Kmr Life Technologies
pGreenhopper pCR2.1-TOPO containing a 4-kbp Mariner-Himar 1 transposon with kanamycin
resistance gene and a 1.2 kbp tnpA transposition gene. Non-replicable in F. tularensis
Unpublished
E. coli
TOP10 General cloning and blue/white screening Life Technologies
F. tularensis
FT12 Type strain, a mouse-passaged isolate of a strain obtained from a U.S. patient McKesson BioServices
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anesthetized during this procedure by an intramuscular
injection of 100 μl of ketamine-acepromazine-xylazine
in accordance with USAMRIID Standard Operating
Procedure AC-09–10.
This study was conducted in compliance with the
Animal Welfare Act and other federal statutes and regu-
lations relating to animals and experiments involving
animals and with adherence to principles stated in the
Guide for the Care and Use of Laboratory Animals
(www.nap.edu/readingroom/books/labrats/chaps.html).
The facility where this research was conducted is fully
accredited by the Association for Assessment and
Accreditation of Laboratory Animal Care International.
The USAMRIID Institutional Animal Care and Use
Committee reviewed and approved the animal protocol
entitled “Pathogenesis studies of F. tularensis mutants in
mice,” (Animal Protocol no. AP-11–013).
Growth rate experiments
Select F. tularensis subsp. tularensis Schu S4 strain
transposon insertion mutants were cultured in chem-
ically defined Chamberlain’s growth medium, and their
growth rates, as determined by optical density measure-
ments at 600 nm (OD600), were compared to those of
the parent strain. Frozen stocks of each mutant and the
parent strain were thawed on ice and diluted into 2 ml
growth media at an OD600 of ~0.150. Culture tubes were
incubated at 37 °C while constrained in a slanted rack
and shaken at 150 rpm. Cultures were sampled for
OD600 readings as a function of time, and their values
were recorded.
Biosafety and biosecurity
The Francisella experiments were conducted in Bio-
safety Level 3 containment laboratories at USAMRIID
with appropriate personal safety and biological select
agents and toxins security measures in place. We do not
anticipate that this report provides knowledge, products,
or technologies that could be directly misapplied by
others to pose a threat to public health and safety,
agricultural crops and other plants, animals, the environ-
ment, or materiel. The Institutional Biosafety Committee
(IBC) that approved this work is composed of members
of the USAMRIID research staff, Commander’s office,
and qualified representatives from external institutions
and is tasked to provide local, institutional oversight of
research using recombinant DNA. The USAMRIID IBC
was established under the U.S. National Institutes of
Health Guidelines for Research Involving Recombinant
DNA Molecules.
50 % Lethal dose estimation
We used Bayesian probit analyses to estimate the lethal
dose response. As a prior distribution, we used a weakly
informative Cauchy distribution with center 0 and scale
10. Parameters were assumed independent of each other.
Using samples from the posterior distribution and inter-
cept parameters from the probit analysis, we estimated the
50 % lethal dose (LD50) and 95 % confidence intervals as
well as the likelihoods of each strain being more or less
potent than any other strain at the median lethality level.
Survival time comparison
We used the Kaplan-Meier method to estimate the
probability of animals surviving a given length of time
[32] and a G-rho class of rank tests to compare differ-
ence between the obtained survival curves [33]. We
calculated all probabilities using the R analysis package
“survival” (Terry Therneau, “A Package for Survival
Analysis in S,” R package version 2.37–7, 2014).
Creation of the expanded human-F. tularensis PPI network
We used the NCBI HomoloGene database of homologs
(www.ncbi.nlm.nih.gov/homologene) to identify human-
murine orthologs [34]. These orthologs were further used
to create sets of 1) conserved PPIs between human-F. tular-
ensis and murine-F. tularensis and 2) expanded F. tularen-
sis-human PPIs consisting of experimentally detected and
orthology-based predicted protein interactions.
We identified the conserved set of PPIs as those PPIs
where the human protein interacted with the same F.
tularensis protein as their murine orthologs. To create
the expanded set of F. tularensis-human PPIs we merged
the human data with orthologous mouse data. To iden-
tify the orthologous data, we first identified the 11 F.
tularensis proteins that had protein interactions with
both hosts. Among these interactions, we identified the
set of murine-F. tularensis PPIs for which there exists a
human ortholog to the murine protein. The resulting
orthologous data set consisted of 76 interactions be-
tween 74 human proteins and the 11 F. tularensis
proteins, corresponding to 64 % of the murine-F. tular-
ensis PPIs. Finally, we merged the human-F. tularensis
experimental and orthologous data sets to create the
expanded set of human-F. tularensis PPIs consisting of
298 unique interactions between 18 F. tularensis and 249
human proteins. These PPI data sets are provided in the
supplementary information (Additional file 2: PPI data).
All networks were plotted in Cytoscape [35] using R
packages iGraph and RCytoscape [36, 37].
Gene Ontology annotation of host genes
We performed two types of Gene Ontology (GO) [38]
enrichment analysis: standard enrichment analysis and
network-based enrichment analysis. Both enrichment
analyses were performed in R using the Bioconductor
packages BioMart [39]. GO annotations were obtained
from BioMart [39]. We used all annotation levels of the
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GO tree, excluding only terms associated with the
root and top two levels. We used the Benjamini and
Hochberg multiple test correction to account for multiple
hypothesis testing [40].
In the standard enrichment analysis, we used the hyper-
geometric distribution to assess the statistical significance
of observing a given GO term in our data. As the comple-
ment of human proteins, we used the set of all human/
murine proteins available in BioMart [39] and anno-
tated with at least one GO term. The reported results
contain only GO terms that were enriched at a ≤20 %
false discovery rate.
Network analysis of host-pathogen PPIs: interaction
modules
In the network-based enrichment analysis, we first
identified connected (sub)networks of the largest con-
nected component (LCC) in the human interactome
that consists of human proteins interacting with at least
one F. tularensis protein and in which all human
proteins were annotated with the same GO term. We
denote these (sub)networks as “interaction modules.”
We then assessed the statistical significance of observ-
ing a given interaction module using Monte Carlo
simulation. Specifically, we assessed probabilities of
observing the same interaction module given 1) a set
of random human proteins of the same size as the
set of human proteins interacting with F. tularensis
and 2) a set of random (randomly rewired) human
PPIs, where the degree (number of interactions) of
each protein was maintained to the same value as in the
full set of human PPIs [20]. We kept only interaction
modules consisting of four or more proteins. For the full
set of human proteins, we used all constituent proteins
from a human PPI network [41]. The reported results
contain only GO terms that were enriched at a ≤5 % false
discovery rate.
Results
In silico identification of potential virulence factors
We used multiple independent strategies to identify
potential virulence factors of F. tularensis subsp. tularen-
sis Schu S4. We initially used orthology to identify eight
proteins present only in six genomes of highly patho-
genic F. tularensis genomes and absent in eight less
pathogenic F. tularensis and seven F. novicida genomes
(Additional file 1: Table S1) [23, 24]. Given the import-
ance of T6SSs in Francisella virulence [21], we further
identified 16 putative proteins with homology to VgrG
domain-containing proteins and, thus, potentially a
component of the T6SS. We used SignalP to identify 290
proteins predicted to be secreted by the general
secretory pathway. Finally, we examined the available
literature on Francisella high-throughput and small-
scale virulence screens to compile a list of 300 proteins
associated with virulence [3–6, 12, 42–44].
Selection of potential virulence factor proteins for Y2H
experiments
To select proteins for experimental evaluation, we first
merged the lists of potential virulence factors and down-
selected proteins based on expert knowledge weighing
the available evidence. As our focus was on detecting
novel virulence factors, we initially excluded proteins
previously studied in animal model experiments. From
the list of predicted secreted proteins, we excluded 226
proteins 1) lacking annotations and predicted to be
secreted with a probability lower than 1.0 or 2) proteins
with annotations but predicted to be secreted with a
probability of <0.9. From the list of 300 experimentally
screened proteins, we excluded capsule proteins whose
role in virulence is controversial [45], acid phosphatases
as they have recently been proven less important for
virulence [46], and metabolic proteins and bacterial
regulators as these proteins are not likely to be secreted.
We also excluded all membrane and transporter proteins
except those that were identified from our comparative
genomics or signal peptide analysis. Furthermore, we
removed type IV pili proteins and proteins associated
with Francisella pathogenicity islands encoding T6SS, as
they have already been extensively studied in animal
model experiments. The exceptions were type IV pili
protein FTT1314c, predicted to be secreted by the
general secretory pathway and putatively associated with
the T2SS [47], and the T6SS proteins FTT1712c (IgIC2)
and FTT1707 (IgIl2) that have been shown to be secreted
in proteomics experiments [15, 48] and to contribute to
pathogenicity [14, 16], but their host interacting partners
are not known. Furthermore, we kept all proteins anno-
tated as hypothetical or of unknown function, as long as
their orthologs were present in the F. tularensis subsp.
tularensis Schu S4 genome.
We further removed all proteins shorter than 90
amino acids and proteins annotated as essential in the
Database of Essential Genes [49], as these latter proteins
would prevent mutant creation. The resulting list of
proteins contained 119 unique potential virulence fac-
tors. Of these, 97 had not previously been tested in
murine models; 22 had been tested in murine models,
but their interactions with host proteins are not known.
We then ranked and grouped the set of 119 proteins
into five groups based on the confidence level we could
associate with each protein as a secreted virulence
factor. We assigned proteins the highest level of confi-
dence for those with multiple known virulence associa-
tions and evidence about attenuation in a mouse animal
model from high-throughput screening of F. tularensis
subsp. tularensis Schu S4 using the Transposon Directed
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Insertion Site Sequencing technique (T.A. Hoover, un-
published data). We assigned the lowest level of confi-
dence to those proteins for which we only had
orthology-based evidence.
Finally, we individually assessed each protein and
down-selected the list into a final, pruned set of 49 puta-
tive and known virulence factors suitable for experimen-
tal evaluation (Table 2).
Y2H screening of host-pathogen interactions
All 49 putative and known virulence factors were
successfully cloned, prepared, and tested in Y2H assays
against both human and murine whole proteome librar-
ies. Y2H screens identified 407 interactions between F.
tularensis baits and human preys and 170 interactions
between F. tularensis baits and murine preys. All baits
were mapped to their corresponding F. tularensis locus
tags, and all preys were mapped to their official gene
symbols as defined in the HUGO Gene Nomenclature
Committee database [50] or Mouse Genome Informat-
ics database [51]. We were not able to map some of the
identified preys to protein coding sequences, and inter-
actions containing those preys were removed. More-
over, we removed protein interactions between F.
tularensis and “sticky” host proteins known to be indis-
criminate binders (F. Schwarz and M. Koegl, unpub-
lished data). The final data consisted of 222 unique
PPIs between 18 F. tularensis and 183 human proteins
and 118 unique PPIs between 13 F. tularensis and 113
murine proteins (Fig. 1). Eleven F. tularensis proteins
interacted with both hosts, seven interacted only with
human proteins, and two interacted only with murine
proteins. As shown in Fig. 1, the majority of F. tularen-
sis proteins interacted with unique host proteins, i.e.,
137 (75 %) human proteins and 110 (97 %) murine
proteins interacted with a single F. tularensis protein.
Furthermore, Y2H screens identified 21 conserved PPIs
between these two data sets, i.e., interactions in which
human proteins interacted with the same F. tularensis
proteins as their murine orthologs. These conserved in-
teractions consisted of six F. tularensis proteins and 20
unique host proteins. Table 2 shows the number of
unique PPIs between each tested F. tularensis protein
and human and murine proteins as well as the corre-
sponding number of conserved interactions in terms of
orthologous pairs of interactions. The small overlap
between F. tularensis-human and F. tularensis-murine
PPIs was potentially due to low quantities of a prey
gene in one of the two cDNA libraries or to non-
exhaustive sampling of host-prey and pathogen-bait
protein interactions. However, the experimental condi-
tions were the same for both sets of experiments. Thus,
our detected interactions represent a subset of all
interactions that can occur.
Transposon mutant selection and in vitro growth
To identify a small set of F. tularensis protein candidates
for validation in animal model experiments, we focused
on nine proteins that interacted with multiple proteins
in both hosts. From this set of proteins, we first removed
two F. tularensis proteins that had already been tested
for virulence attenuation in animal models: FTT0356
[44] and FTT0626 [43]. We then evaluated and ranked
each of the remaining seven proteins based on the number
of conserved interactions in which they participate or
based on involvement of their host targets in biological
processes and pathways related to virulence, e.g., signaling
and apoptosis. This procedure resulted in seven pre-
viously uncharacterized virulence factor candidates:
FTT0482c, FTT0842, FTT0902, FTT1029, FTT1538c,
FTT1564, and FTT1597.
We successfully obtained from the transposon library
insertion mutants in the F. tularensis subsp. tularensis Schu
S4 strain for five virulence factor candidates (FTT0482c,
FTT0902, FTT1538c, FTT1564, and FTT1597). We were
unable to obtain an insertion mutant for the peptidoglycan-
associated lipoprotein FTT0842 and FTT1029. Growth rate
experiments in Chamberlain’s chemically defined growth
medium [52] during the exponential phase showed that
there was no significant difference in the growth rate for
the mutants compared with those of the parent strain
except for ΔFTT1564, which showed a minor growth
enhancement (Additional file 3: Table S2).
The created transposon mutants are potentially subject
to polar effects. Based on available computational bio-
informatics information in the DOOR [53] and ProOpDB
[54] databases, FTT0482c and FTT1597 belong to anno-
tated single-gene operons; thus, they should not be associ-
ated with polar effects. On the other hand, FTT1538c
belongs to an operon of four genes (FTT1537c to
FTT1540c) and polar effects are theoretically possible.
Further studies are required to definitively determine
possible polar effects.
Virulence attenuation in a murine intranasal infection
model
Using intranasal infection, we gauged the effects of the
five insertion mutations on F. tularensis virulence
relative to the fully virulent wild-type F. tularensis subsp.
tularensis Schu S4 strain. A total of 360 BALB/c mice
[10 mice for each of six doses of increasing numbers
of colony-forming units (CFUs) for each of the six
strains (five mutant strains + the wild-type strain)]
were exposed to different intranasal doses ranging
from ≥0.03 CFU to ≥78,000 CFU and monitored for
21 days (Additional file 4: Table S3 and Additional file 5:
Figure S1). We used these dose-response experiments to
estimate the lethal dose for each strain and compare
the potency of each strain. Estimated wild-type LD50
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Table 2 List of proteins selected for experimental yeast two-hybrid evaluation
Group Locus ID Name Description Interactions
Human Mouse Common
1 FTT0369c DipA Deficient in intracellular replication A - - -
FTT0584 - Unknown - - -
FTT0901 LpnA Lipoprotein - 1 -
FTT0918 FopC Outer membrane lipoprotein - - -
FTT1103 DsbA Conserved hypothetical lipoprotein - - -
FTT1179 BipA GTP binding translational elongation factor Tu 29 - -
FTT1508c RelA GTP pyrophosphokinase 3 - -
FTT1726 YegQ Protease YegQ - - -
FTT1676 - Protein of unknown function, membrane protein - - -
FTT0356 HtpG Chaperone, heat shock protein HtpG, ATPase activity 20 1 1
FTT0626 Lon Chaperone, ATP-dependent DNA-binding protease Lon 2 2 -
FTT1769c ClpB Chaperone, ATP-dependent CLP protease ATP-binding subunit ClpB - - -
FTT1712c IglC2 Intracellular growth locus, subunit C 43 33 1
FTT0068 SodB Superoxide dismutase - 12 -
FTT1707 IglI2 Uncharacterized protein - - -
2 FTT0013c - Protein of unknown function - - -
FTT0295 - Hypothetical protein - - -
FTT0520 - Putative uncharacterized protein - - -
FTT0842 - Peptidoglycan-associated lipoprotein 9 17 -
FTT0902 - Protein of unknown function 8 1 -
FTT0975 - Protein of unknown function - - -
FTT1039 DacB1 D-Alanyl-D-alanine carboxypeptidase (penicillin-binding protein) family protein - - -
FTT1040 - Lipoprotein - - -
FTT1334c - Hypothetical protein 1 1 -
FTT1402c - Protein of unknown function - - -
FTT1538c - Hypothetical protein 25 22 -
FTT1549 - Protein of unknown function - - -
FTT1626c - Hypothetical protein - - -
FTT1688 - Aromatic amino acid HAAP transporter - - -
FTT1314c PilE6 Type IV pili fiber building block protein 4 - -
FTT1776c - Hypothetical protein 2 - -
3 FTT0086 - Conserved protein of unknown function - - -
FTT0103c - Hypothetical protein 2 - -
FTT0792 - LPS locus - - -
FTT0889c - Type IV pili fiber building block protein - - -
FTT1530 FadB/AcbP Bifunctional 3-hydroxacyl-CoA dehydrogenase - - -
FTT1564 - Polyphosphate kinase 9 6 1
4 FTT0018 - Secretion protein 10 - -
FTT0296 Pcp Pyrrolidone-carboxylate peptidase - - -
FTT0482c - Lipoprotein 32 14 11
FTT1029 DacD D-Alanyl-D-alanine carboxypeptidase (penicillin binding protein) family protein 5 2 2
FTT1157c - Type IV pili lipoprotein - - -
FTT1242 - Hypothetical protein - - -
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of 2.62 CFU (Fig. 2 and Table 3) agreed with previously
estimated doses for the wild-type strain [9]. Table 3 also
shows that the estimated LD50 values for ΔFTT0482c,
ΔFTT1538c, and ΔFTT1597 were above the wild-type
dose. Further analysis showed that the LD50 values
for these three mutant strains were statistically larger
(p-value ≤0.03) than the LD50 values of either the
wild-type strain or the other two mutant strains
(Additional file 6: Table S4).
The FTT0902 mutant showed a minute absolute
increase in virulence that may be testing the limit of
the experimental setup in terms of measureable
CFUs. Although FTT0902 does not code for a
known protein, it appears to have lipoprotein charac-
teristics based on inspection of the amino terminus,
potentially affecting the outer surface of F. tularen-
sis. Such minor morphological changes may affect
clumping of cells during the preparation of challenge
doses and lead to an undercounting of the true dose.
Conversely, the possibility that this mutant was
really more virulent in the murine model of tular-
emia could not be ruled out based on our experi-
ments, and, hence, we did not consider ΔFTT0902
for further evaluation.
Given these results, we compared the survival curves
of mice exposed to the ΔFTT0482c, ΔFTT1538c, and
ΔFTT1597 mutant strains for intranasal doses of ≥78 CFU
(≥30 LD50) to mice exposed to a wild-type strain dose
of 320 CFU (122 LD50). Figure 3 shows that on the
fifth day, all wild-type mice exposed to the high-dose
Table 2 List of proteins selected for experimental yeast two-hybrid evaluation (Continued)
FTT1591 VacJ Lipoprotein - - -
FTT1746 - Peptidase - - -
5 FTT1597 - Putative uncharacterized protein 16 6 6
FTT0522 - Hypothetical protein, methyltransferase domain - - -
FTT0604 - Hypothetical protein, methyltransferase domain - - -
FTT0677c - Putative uncharacterized protein 2 - -
Group 1, multiple virulence association evidences and evidence about attenuation in an animal model; group 2, multiple virulence association evidences; group 3,
transposon mutant screening evidence only; group 4, predicted secretion evidence only; group 5, orthology evidence only
Fig. 1 Yeast two-hybrid (Y2H) host-pathogen protein-protein interactions (PPIs). Using Y2H screens against whole human and murine proteome
libraries, we identified 222 unique PPIs between 18 Francisella tularensis proteins and 183 human proteins (a) and 118 unique PPIs between 13 F.
tularensis proteins and 113 murine proteins (b). Green nodes represent F. tularensis proteins, whereas pink and red nodes represent host proteins.
Eleven F. tularensis proteins interacted with both hosts, and six of them participated in 21 conserved interactions (red edges), i.e., six F. tularensis
proteins that interacted with both human proteins (red nodes in a) and their murine orthologs (red nodes in b)
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died. Conversely, mice exposed to mutant strains
tended to have a slower time to death (nine of ten
mice exposed to ΔFTT1538c died by day 9) as well
as survived in larger numbers (five mice exposed to
ΔFTT1597 and four mice exposed to ΔFTT0482c
survived 21 days post-exposure). A survival-curve
analysis indicated that the difference in survival times
between mutant strains and the wild-type strain was
statistically significant (p-value ≤10-3). Although the
values in terms of CFUs are modest for the three mu-
tants, and may not be of biological significance for
FTT1538c, all results showed a consistent increase in
CFUs. Thus, these results demonstrate that these three
mutants showed attenuated virulence when used to
challenge BALB/c mice via the intranasal route of in-
fection and, therefore, implicated three F. tularensis
proteins not previously considered factors for in vivo
virulence.
Pairwise Y2H experiments for select human-F. tularensis
virulence factors PPIs
To further assess confidence in the identified host-
pathogen interactions from our high-throughput Y2H
screen, we retested a small number of host-F. tularensis
protein interactions using pairwise Y2H assays. We
focused only on interactions including the identified novel
virulence factors (FTT0482c, FTT1538c, and FTT1597)
and their interacting human protein partners. To select
the human protein interaction partners from the larger
data set, we examined and ranked each protein based on
involvement in biological processes or pathways associ-
ated with F. tularensis pathogenicity, conservation among
species, and ability to interact with more than one of the
three virulence factors. Using this procedure, we selected
12 human-F. tularensis interactions for retesting and con-
firmed four interactions in this assay: FTT0482c with WD
repeat-containing protein 48 (WDR48), FTT1538c with
Fig. 2 Fifty percent lethal dose (LD50) estimation. Using the dose-response experiments, we estimated LD50 values and 95 % confidence intervals
for the wild-type strain and each of the mutant strains. The estimated wild-type LD50 of 2.62 CFU, where CFU denote colony-forming units,
agreed with previously estimated values for the wild-type F. tularensis subsp. tularensis Schu S4 strain. The estimated LD50 values for ΔFTT0482c
and ΔFTT1597 were higher than the wild-type value and outside its 95 % confidence intervals, whereas the LD50 value estimated for ΔFTT1538c
was above the wild-type value, although with overlapping confidence intervals. These results support the notion that ΔFTT0482c, ΔFTT1538c, and
ΔFTT1597 attenuate F. tularensis virulence in this animal model
Table 3 LD50 estimation
Strain Log10(CFU) 95 % confidence intervals CFU 95 % confidence intervals
Median Lower Upper Median Lower Upper
Wild type 0.42 0.02 0.81 2.62 1.06 6.43
ΔFTT0482c 1.77a 1.46 2.08 59.14a 28.82 121.04
ΔFTT0902 -1.14 -2.01 -0.52 0.07 0.01 0.30
ΔFTT1538c 0.97a 0.57 1.38 9.26a 3.68 24.16
ΔFTT1564 0.63 0.46 0.80 4.29 2.86 6.26
ΔFTT1597 1.59a 1.13 2.07 38.66a 13.36 116.48
Estimated 50 % lethal dose (LD50) values for the F. tularensis subsp. tularensis Schu S4 wild-type strain and the following five mutant strains: ΔFTT0482c, ΔFTT0902,
ΔFTT1538c, ΔFTT1564, and ΔFTT1597. CFU, colony-forming units. aLD50 values above the wild-type LD50 value
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78-kDa glucose-regulated protein (HSPA5), FTT1538c
with WDR48, and FTT1597 with AP-3 complex subunit
mu-1 (AP3M1). The success rate of 33 % was less than
the expected 50-80 % rate, although not necessarily out of
line with earlier reports of retesting Y2H interactions
using similar assay conditions [55–57]. One reason for the
lower reproducibility rate was that the isoforms of the
genes used for the retests might not be identical to what
we identified in the high-throughput cDNA library screen-
ing, as the sequencing reads for the preys provide infor-
mation for only part of the cDNA. In the retesting, we
used the additionally constructed human clones to identify
three new interactions that were not detected in our
original high-throughput screening: FTT1538c/AP3M1,
FTT1597/WDR48, and FTT1597/Quaking (QKI). All
retest results are shown in supplemental information
(Additional file 7: Table S5).
The pairwise retesting of the Y2H interactions does
not constitute a methodology-independent verification
of the initial screening results. We attempted two
independent approaches to verify select interaction
from the Y2H assays, i.e., 1) one bait-one prey inter-
action verification by recombinant expression of bait
and prey genes followed by co-immunoprecipitation
and LUminescence-based Mammalian IntERactome
(LUMIER) assays and 2) affinity purification/mass
spectrometry (AP/MS) assays. We restricted these studies
to three F. tularensis targets – FTT1597, FTT0482c, and
FTT1564 – that interacted with four human proteins.
Although we successfully cloned all three selected F.
tularensis genes and three of the four selected human
genes into the LUMIER expression vectors and
transfected them into the human HEK293T cell line, we
were essentially unable to express the bacterial proteins
using multiple expression vectors. It may not be bio-
logically feasible to express the selected bacterial genes
in mammalian cell lines, as complex folding and post-
translational processing may not be reproducible in the
in vitro environment.
Discussion
Using Y2H methods to detect Francisella-human protein
interactions
Protein-interaction detection based on random cDNA
libraries and Y2H technology is associated with well-
known experimental and biological biases leading to
mixed confidence and confusion about the reliability of
the observed interactions. Prime is the often-noted non-
repeatability of observed Y2H interactions, primarily
stemming from insufficient retesting [58]. It is not
practical to repeat screens exhaustively to recover all
possible Y2H interaction high-throughput experiments.
Although more testing increases confidence of multiple
observed interactions, the absence of an interaction
may not indicate that the interaction cannot occur, just
that the experimental or biological conditions were not
amenable to sample that interaction. A further uncertainty
on the biological level is that presence of an Y2H inter-
action does not necessarily indicate that the interaction
actually occurs, just that it can occur.
Comparison of high-throughput data sets. Our study is
not the first study to screen for interactions between
human and F. tularensis proteins. However, it is the first
study to systematically use targeted screens to identify
Fig. 3 Mouse intranasal challenge model results. We compared the survival rates of 30 (3 × 10) mice exposed to the ΔFTT0482c, ΔFTT1538c, and
ΔFTT1597 mutants for intranasal doses of ≥78 CFUs, with 10 mice exposed to wild-type strain doses of 320 CFU. Animals were monitored for
21 days. All mice exposed to the high-dose of the wild-type strain died by the end of the fifth day (blue line), whereas mice exposed to mutant
strains had a slower time to death and survived in larger numbers 21 days post-exposure (purple, red, and orange lines). There was a statistically
significant difference in the survival rate of mice exposed to mutant strains and mice exposed to the wild-type strain (p-value ≤10-3). These results
support the notion that each of the three mutants attenuates virulence when infected in mice via the intranasal route of infection
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potential F. tularensis virulence factors and PPIs asso-
ciated with secretion system proteins. In contrast,
Dyer et al. [59] used a random genome library of F.
tularensis as baits (DNA-binding domain) and human
cDNA libraries as preys (activation domain) to identify
host-pathogen interactions using Y2H technology.
This study reported 1,383 host-pathogen interactions
between 999 human and 415 F. tularensis proteins.
We found that 24 proteins from our list of 49 F. tular-
ensis putative and known virulence factors were
present in the Dyer et al. data set, with nine proteins
associated with 180 interactions in our data set.
Although these nine proteins participated in 43 PPIs
in the Dyer et al. study, there was no overlap among
these interactions and our data set. This result is again
a consequence of the variations in the libraries, Y2H
vectors, and strains used in terms of different bait/
prey clone properties and laboratory procedures. For
example, Dyer et al. screened random fragments of F.
tularensis genomic DNA, whereas we used full-length
ORF clones. Similar low overlaps have been noted
among Helicobacter pylori proteins [56] and for Yersinia
pestis host-pathogen PPIs obtained by random library and
systematic Y2H screening [60].
Analysis of virulence factor interactions and infectivity
mechanisms
We have chosen to organize the discussion of virulence
factor interactions with host proteins into three sections
(I-III) based on the level of interaction confidence. Thus,
the first analysis was based on highest confidence data,
consisting of the successfully retested Y2H interactions,
for the three novel in vivo validated virulence factors
identified here. Second, we used all Y2H data for the
two previously known virulence factors included in our
data set to assess their possible contribution to Francisella
pathogenicity. Finally, we present an analysis of potential
Francisella infectivity mechanisms that factors in all
detected Y2H interactions in identifying targeted human
proteins and protein interaction networks.
I – Novel virulence factors and their PPI-inferred virulence
phenotypes
Little prior knowledge exists on the function or role of
virulence factor proteins FTT0482c, FTT1538c, and
FTT1597; only FTT0482c has been assigned functionality
as a hypothetical lipoprotein. Here, we positively identified
them as virulence factors that do not influence normal
bacterial growth yet affect lethality in an intranasal murine
challenge model. Furthermore, we can hypothesize on
their possible roles using the measured Y2H interaction
profiles with human proteins in promoting Francisella
intracellular lifestyle and pathogenicity.
The interactions of FTT1538c with AP3M1, WDR48,
and HSPA5 strongly link this protein to biological
processes involved in human intracellular transport.
AP3M1 is a component of an adaptor complex involved
in the Golgi to endosome/lysosome intracellular protein
trafficking, in particular from the early endosome to
the late endosome compartment [61]. Binding to and
interfering with this adaptor complex could alter en-
dosome maturation or endosome-lysosome fusion.
Similarly targeting lysosomal degradation processes,
FTT1538c binding or interacting with WDR48, known
to regulate deubiquitinating complexes [62], could
provide a mechanism to interfere with ubiquitin tag-
ging of pathogen protein and prevent their targeted
destruction. HSPA5 belongs to the family of 70-kDa
heat shock proteins generally found in the endoplas-
mic reticulum; however, it is associated with multiple
cellular locations and functions, including the unfolded
protein response, protein transport, and interactions with
apoptotic executors [63].
Consistent with these interactions/targets, host
targets identified in the high-throughput Y2H include
SNARE protein STX8, a protein known to be required for
late endosome trafficking [63], and PI4K2B, involved in
overall phosphatidylinositol 4-kinase activity and protein
trafficking [64]. Furthermore, GO enrichment analysis of
all host proteins that interact with FTT1538c also indi-
cated enrichment of membrane-bound vesicular proteins
(padj = 0.05). Thus, the interaction data are compatible
with FTT1538c contributing to intracellular survival by
interfering with vesicular trafficking, possibly during
endosome and lysosome fusion during phagocytosis, and
ultimately contributing to phagosomal escape.
Although lacking functional annotation, FTT1597
contains tetratricopeptide repeat motifs recently shown
to be present in other proteins implicated in F. tularen-
sis virulence [65]. The similarity in interactions with
AP3M1 and WDR48 highlight a possible functional
similarity to FTT1538c. Further linking the functional-
ities, in the high-throughput Y2H data set, FTT1597
interacted with DNAJB11, a co-chaperone of HSPA5.
On the other hand, the observed interaction with QK1,
an RNA-binding protein that regulates mRNA activities, is
not known to be linked to any of these functionalities.
Lipoprotein FTT0482c interacted with WDR48, which
thus was a common host interaction among all the
identified virulence factors. Five other interacting host
proteins in high-throughput screening share this involve-
ment in targeting ubiquitination related proteins/pro-
cesses (ANAPC10, CACYBP, RANBP2, UBE2V2, and
XPA). In these experiments, FTT0482c also interacted
with the renin receptor ATP6AP2, which activates the
ERK inflammatory pathway and whose inhibition is
associated with decreased phagocytosis [66].
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II – Phenotypic associations of known virulence factors
Turning to the interaction analysis of known virulence fac-
tors based on the high-throughput Y2H screens, we exam-
ined identified PPIs for known virulence factors and those
highly implicated in virulence for binding to host protein
targets. A lack of host protein interactions does not neces-
sarily imply a lack of a biological role in virulence, as viru-
lence factor proteins may be involved in functions other
than protein binding as detectable by the Y2H screens.
Our screens identified a total of 76 and 12 interac-
tions for FTT1712c (IglC2) and FTT0068 (SodB),
respectively (Table 2). IglC2 interacted with proteins
from both hosts, whereas SodB interacted only with
murine proteins. IglC2 is a Francisella pathogenicity
island protein (and a member of T6SS), which has already
been identified as a protein required for intracellular
growth, phagosomal escape, regulation of host signaling,
and apoptosis [7, 67–69]. We identified 43 interactions
between IglC2 and human proteins and 33 interactions
between IglC2 and murine proteins, the largest number of
interactions detected for any F. tularensis protein in our
screens. We found that IglC2 interacted with a set of
proteins that are linked to the inflammatory response
and activation of cAMP signaling pathway stimulation via
mitogen-activated protein kinases, i.e., phosphatidylinositol
3,4,5-trisphosphate 3-phosphatase (PTEN), fibroblast
growth factor receptor substrate 2 (FRS2), and transcrip-
tion factor AP-1 (JUN). As these proteins are intimately
linked to host cell defense and immune responses [10, 70],
they provide important targets for immune suppression
and the successful establishment of an infection.
For SodB that has been identified as a factor in F. tularen-
sis oxidative stress protection [71], we found multiple po-
tential interacting partners, including interactions with the
murine thioredoxin-interacting protein Txnip, a protein
mediating oxidative stress via thioredoxin activity [72].
Furthermore, we identified interactions for five
additional proteins from the first group of proteins, i.e.,
those highly implicated in virulence (Table 2). For two of
those, heat shock protein FTT0356 (HtpG) [11] and
GTP-binding translational elongation factor FTT1179
(BipA) [43], we found interactions with human proteins
but only one murine interaction, even though murine
orthologs exists. For the remaining three proteins
(LpnA, RelA, and Lon) we only found a scatter of inter-
actions that did not point toward any specific protein
interaction pattern or biological process.
III – Characterization of F. tularensis infectivity based on
its host targets
It was not possible to perform a statistically meaning-
ful evaluation of the roles of each individual F. tular-
ensis protein due to the overall small number of
identified host-pathogen protein interactions. Instead,
given that the selected set of 49 bacterial proteins
was strongly biased toward secreted/virulence associ-
ated protein, we used the aggregated host-pathogen
interaction data set to investigate host molecular mecha-
nisms targeted by the selected subset of F. tularensis pro-
teins. The aggregated data set contains all experimentally
detected human-F. tularensis PPIs and computationally
derived human (murine orthologs)-F. tularensis PPIs and
consists of 298 unique interactions between 18 F. tularen-
sis and 249 human proteins.
First, we performed enrichment analyses based on
GO annotation as outlined in the METHODS. Table 4
shows that F. tularensis proteins target a statistically
significant number of host proteins located in or
around the endoplasmic reticulum and Golgi com-
partments. Known pathogen targets in these compart-
ments are linked to activation of protein degradation
processes [73].
Second, we used the host PPI network to investigate
the influence of the pathogen on host proteins and
interactions between host proteins [20]. We mapped
proteins from the merged human-F. tularensis PPI
data set onto a human PPI network consisting of
76,043 physical PPIs among 11,688 proteins [41]. Of
the 249 human proteins interacting with F. tularensis
proteins, 194 (~78 %) were found in the human net-
work. Furthermore, we found that 52 of these human
proteins were a part of the LCC, i.e., the largest subnet-
work in which a path connects every two proteins to
each other. The size of this LCC was significantly larger
than what could be expected by random chance in the
human PPI network, i.e., Nran = 9.1, σran = 6.4. Within
this LCC, we identified 139 sets of human PPIs in
which, in each set, all human proteins interacted with
at least one of the 18 F. tularensis proteins and had the
same GO biological process annotations; we denoted
these sets as interaction modules [20]. Table 5 shows
12 interaction modules that correspond to the most
specific (lowest level) GO annotations of all identified
interaction modules. These interaction modules are
associated with biological processes related to cellular
regulation, signaling, cellular response, and protein
modification.
It has been shown that a number of bacterial pathogens
interfere with host signaling pathways to obstruct host
defense systems and promote pathogen colonization
[74–76]. Indeed, the largest number of proteins in the
LCC was involved in signaling, and we identified two
statistically significant signaling interaction modules,
containing eight and five host proteins (Fig. 4, shaded
areas). The larger interaction module contained pro-
teins related to defense responses, whereas the smaller
interaction module mostly contained proteins related to
intracellular signaling. Our analysis also identified 18
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stress response proteins in the LCC, 16 of which were
also annotated as signaling proteins. One of the
remaining two proteins was aldo-keto reductase family
1 protein (AKR1B1), a protein involved in the stress
response [77], which links the two interaction modules.
The other stress response protein, chromobox protein
homolog 5 (CBX5), links the larger signaling inter-
action module and signal transducing adapter molecule
2 (STAM2), which is associated with the immune system
response. Further assessment of proteins from the LCC
revealed additional proteins associated with signaling (blue
octagons) [78]. Overall, the identified signaling stress
response component consists of 50 % of proteins from the
LCC (26 proteins). These results suggest that proteins
involved in cell-to-cell signaling and innate immune
defense responses are potential targets for Francisella;
furthermore, it also points toward the interactions
among these host proteins as equally important
targets.
Conclusions
Direct interactions with specific host proteins and the
ability to influence host PPIs are important components
for intracellular pathogens to avoid host-cell defense
mechanisms and successfully establish an infection.
Although direct host-pathogen protein-protein binding is
only one aspect of virulence, it is a critical component in
directly manipulating and interfering with cellular
processes in the host cell. Here, we exploited this
using an integrated bioinformatics/proteomics method
Table 4 Enrichment of GO terms for human proteins interacting with F. tularensis
GO term ID GO term description Number of proteins p-value FDR
Cellular localization GO:0005793 Endoplasmic reticulum-Golgi intermediate compartment 4 2.7 10-3 0.04
GO:0005788 Endoplasmic reticulum lumen 6 1.7 10-3 0.03
GO:0005801 Cis-Golgi network 3 3.6 10-3 0.05
GO:0005720 Nuclear heterochromatin 3 3.6 10-3 0.05
GO:0042470 Melanosome 7 9.5 10-5 0.00
GO:0042588 Zymogen granule 3 3.3 10-3 0.01
GO:0035097 Histone methyltransferase complex 4 3.8 10-3 0.05
GO:0031519 PcG protein complex 3 5.1 10-3 0.06
Molecular function GO:0051082 Unfolded protein binding 6 1.9 10-3 0.18
GO:0019904 Protein domain specific binding 14 3.6 10-3 0.18
FDR, false discovery rate calculated using Benjamini and Hochberg multiple test correction [40]; GO, Gene Ontology
Table 5 Enrichment of GO biological processes in host subnetworks
Category Term Size p-value
ID Description NC NM pGO pRp pRn
Cellular regulation GO:0045944 Positive regulation of transcription from RNA polymerase II promoter 7 4 6.4 10-3 1.0 10-4 1.5 10-4
GO:0045892 Negative regulation of transcription, DNA-dependent 11 6 0.0 0.0 1.3 10-4
GO:0051090 Regulation of sequence-specific DNA binding transcription factor activity 6 4 1.1 10-3 0.0 1.1 10-4
GO:0051345 Positive regulation of hydrolase activity 8 5 4.0 10-4 0.0 7.7 10-5
GO:0051726 Regulation of cell cycle 9 4 6.0 10-4 7.0 10-4 1.1 10-3
Cellular signaling GO:0023052 Signaling 22 8 9.2 10-3 0.0 1.1 10-3
GO:0007166 Cell surface receptor signaling pathway 15 5 3.4 10-3 6.0 10-4 1.8 10-3
Cellular response GO:0070887 Cellular response to chemical stimulus 17 7 0.0 0.0 4.0 10-4
GO:0006950 Response to stress 18 10 4.0 10-3 0.0 4.5 10-4
GO:0010033 Response to organic substance 17 8 0.0 0.0 4.6 10-4
Protein modification GO:0016567 Protein ubiquitination 9 4 0.0 1.0 10-4 2.9 10-5
GO:0016310 Phosphorylation 10 5 9.7 10-3 2.0 10-4 1.1 10-4
NC, number of proteins in the largest connected component annotated with a given term; NM, number of proteins in the largest interaction module for a given
term; pGO, probability of the same number of proteins as NC being annotated with a given GO term solely through a random selection; pRn, probability
that a given number of proteins as NM are annotated with a given GO term solely through random selection in a random network that has the same
degree distribution as the human network; pRp, probability that a given number of proteins as NM are annotated with a given GO term solely through
random selection. This table contains only the largest statistically significant interaction module for each term; the complete list is available as
supplementary information (Additional file 8: Table S6).
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to identify both virulence factors and their comple-
ment of interacting host proteins.
The implemented approach of selecting a focused
set of putative virulence factors based on multiple
evidence, down-selection through in vitro high-
throughput Y2H screening, and final assessment using
mutants in an animal infection model was highly
effective. Of the final five mutants selected for animal
testing, three showed statistically significant virulence
attenuation that was not directly attributable to gross
bacterial growth defects of the tested mutants. Fur-
thermore, the up-front Y2H screening and subsequent
retesting of select host-pathogen protein interactions
provided indications as to possible virulence mecha-
nisms associated with the direct binding of the viru-
lence factors to host proteins. This led to an initial
hypothesis as to which host processes were targeted by
the three virulence factors FTT0482c, FTT1538c, and
FTT1597, in particular identifying intracellular protein
trafficking between the early endosome to the late
endosome as an important component in virulence
attenuation. We also used the Y2H data to investigate
host protein binding of two known virulence factors,
showing that direct protein binding was a component
in the modulation of the inflammatory response via
activation of mitogen-activated protein kinases and in
the oxidative stress response.
Availability of supporting data
The data sets supporting the results of this article are
included within the article and its additional files.
Fig. 4 Host signaling and the stress response as a F. tularensis virulence factor target. F. tularensis proteins target a large number of host
proteins involved in signaling (red and blue octagons) and the stress response (yellow diamond). Using the connectivity and Gene
Ontology (GO) annotation, we identified two statistically significant signaling interaction modules, one containing eight host proteins and
one containing five host proteins (shaded area). The larger one contains proteins related to the immune system response, whereas the
smaller one contains proteins related to intracellular signaling. Further annotation assessment of proteins from the largest connected
component (LCC) revealed additional proteins associated with signaling (blue octagons) and existing interaction modules. These results
suggest that F. tularensis targets host proteins involved in signaling to interfere with cell-to-cell signaling and the immune response but
also points toward PPIs among these host proteins as equally important targets
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